IMODI Cancer
Created in 2013
- BETA
To investigate (B)
Some signals may appear as inconsistent with a regular activity Social networks
76 189Activities
Technologies
Entity types
Location
20 Rue Jean Mazen, 21000 Dijon, France
Dijon
France
Employees
Scale: 51-200
Engaged corporates
1
0 0Added in Motherbase
1 year, 8 months ago
biotech Value proposition
Building a sustainable sector and accelerate the discovery of new treatments tailored to each patient.
French consortium to develop new experimental models of cancer in 9 cancer pathologies of interest (Lung, Pancreas, Breast, Liver, Ovary...)
3 major R&D axes:
- Developing in vivo models and cell-based assays
- Mimicking the human biology by humanizing the tumor microenvironment in mice
- Studying the microbiota in cancer patients
Oncology, Cancer research, Patient derived Xenograft, Cell lines, Ex vivo assays, Microbiota, Data mining , Translationnal medecine, Humanized mice, Biomarker, Research and Development, In vivo models, Ex vivo models, and CancerOriginal language
Building a sustainable sector and accelerate the discovery of new treatments tailored to each patient.
French consortium to develop new experimental models of cancer in 9 cancer pathologies of interest (Lung, Pancreas, Breast, Liver, Ovary...)
3 major R&D axes:
- Developing in vivo models and cell-based assays
- Mimicking the human biology by humanizing the tumor microenvironment in mice
- Studying the microbiota in cancer patients
Home - IMODI Cancer
Aggregating scientific expertise and technologies around the development of innovative and more valuable models of cancers
https://imodi-cancer.org/
